The association between the ring finger protein 213 (RNF213) polymorphisms and moyamoya disease susceptibility: a meta-analysis based on case–control studies
- 5 February 2016
- journal article
- research article
- Published by Springer Science and Business Media LLC in Molecular Genetics and Genomics
- Vol. 291 (3), 1193-1203
- https://doi.org/10.1007/s00438-016-1172-5
Abstract
A number of studies assessed the association of ring finger protein 213 (RNF213) gene polymorphisms with moyamoya disease (MMD), but the results were not entirely consistent. This meta-analysis was performed to explore the relationship between RNF213 polymorphisms and moyamoya disease in Asian population. A systematic search from the PubMed, MEDLINE, EMBASE, ISI web of science, CNKI, China CBM and WANFANG DATA databases was conducted to retrieve published studies until March 2015. Statistical analyses were performed using the STATA12.0 software. Fixed or random effects model, subgroup analysis, sensitivity analysis, and publication bias were used to improve the comprehensive analysis. Eight papers including 904 MMD patients and 2258 controls were recruited in the meta-analysis. rs112735431 was closely associated with the risk of MMD among Asian population in all genetic models (dominant model: OR 103.39, 95 % CI 52.25–204.55, P = 1.69e−40; recessive model: OR 16.45, 95 % CI 6.00–45.10, P = 5.33e−08; additive model: OR 61.49, 95 % CI 22.07–171.33, P = 3.32e−15), especially in the Japanese population. Subgroup analysis revealed highly statistically significant higher risk in the patients with family histories. Although another polymorphism rs148731719 showed no significant association with the MMD, rs138130613 was found to be related to the higher risk in Chinese population (dominant model: OR 8.34, 95 % CI 1.72–40.47, P = 0.008). Our meta-analysis strengthens RNF213 rs112735431 is closely associated with the increased risk of MMD in Japanese, and the screening combined with rs112735431 and rs138130613may improve the detection rate for MMD in China.Keywords
Funding Information
- National Natural Science Foundation of China (NSFC 81471180)
This publication has 36 references indexed in Scilit:
- RNF213 polymorphism and Moyamoya disease: A systematic review and meta-analysisNeurology India, 2013
- Identification of a Genetic Variant Common to Moyamoya Disease and Intracranial Major Artery Stenosis/OcclusionStroke, 2012
- Molecular Analysis of RNF213 Gene for Moyamoya Disease in the Chinese Han PopulationPLOS ONE, 2012
- Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya diseaseNeurology, 2012
- Clinical Features, Prothrombotic Risk Factors, and Long-Term Follow-Up of Eight Pediatric Moyamoya PatientsJournal of Clinical Neurology, 2012
- Identification of RNF213 as a Susceptibility Gene for Moyamoya Disease and Its Possible Role in Vascular DevelopmentPLOS ONE, 2011
- Moyamoya Disease and Moyamoya SyndromeThe New England Journal of Medicine, 2009
- Novel epidemiological features of moyamoya diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2008
- Prevalence and Clinicoepidemiological Features of Moyamoya Disease in JapanStroke, 2008
- A novel susceptibility locus for moyamoya disease on chromosome 8q23Journal of Human Genetics, 2004